...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019

RVXOT - Since it was a cardiovascular trial it seems kind of obvious that they were referring to cardiovascular disease patients that happened to have cognitive decline.

tada

Share
New Message
Please login to post a reply